1,387
Views
0
CrossRef citations to date
0
Altmetric
Research Article

No increased mortality after total hip arthroplasty in patients with a history of pediatric hip disease: a matched, population-based cohort study on 4,043 patients

, &

  • Bland J M, Altman D G. Matching. BMJ 1994; 309(6962): 1128.
  • Cnudde P, Rolfson O, Timperley A J, Garland A, Kärrholm J, Garellick G, Nemes S. Do patients live longer after THA and is the relative survival diagnosis-specific? Clin Orthop Relat Res 2018; 476(6): 1166–75.
  • Engesaeter L B, Engesaeter I Ø, Fenstad A M, Havelin L I, Kärrholm J, Garellick G, Pedersen A B, Overgaard S. Low revision rate after total hip arthroplasty in patients with pediatric hip diseases. Acta Orthop 2012; 83(5): 436–41.
  • Fang M, Noiseux N, Linson E, Cram P. The effect of advancing age on total joint replacement outcomes. Geriatr Orthop Surg Rehabil 2015; 6(3): 173–9.
  • Froberg L, Christensen F, Pedersen N W, Overgaard S. The need for total hip arthroplasty in Perthes disease: a long-term study. Clin Orthop Relat Res 2011; 469(4): 1134–40.
  • Garland A, Rolfson O, Garellick G, Kärrholm J, Hailer N P. Early postoperative mortality after simultaneous or staged bilateral primary total hip arthroplasty: an observational register study from the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2015; 16: 77.
  • Gordon M, Rysinska A, Garland A, Rolfson O, Aspberg S, Eisler T, Garellick G, Stark A, Hailer N P, Sköldenberg O. Increased long-term cardiovascular risk after total hip arthroplasty. Medicine (Baltimore) 2016; 95(6): e2662.
  • Hailer Y D. Fate of patients with slipped capital femoral epiphysis (SCFE) in later life: risk of obesity, hypothyroidism, and death in 2,564 patients with SCFE compared with 25,638 controls. Acta Orthop 2020; 91(4): 457–63.
  • Hailer Y D, Hailer N P. Is Legg–Calvé–Perthes disease a local manifestation of a systemic condition? Clin Orthop Relat Res 2018; 476(5): 1055–64.
  • Hailer Y D, Nilsson O. Legg–Calvé–Perthes disease and the risk of ADHD, depression, and mortality. Acta Orthop 2014; 85(5): 501–5.
  • Hailer Y D, Montgomery S M, Ekbom A, Nilsson O S, Bahmanyar S. Legg-Calvé-Perthes disease and risks for cardiovascular diseases and blood diseases. Pediatrics 2010; 125(6): e1308–e1315. DOI:
  • Hailer N P, Garland A, Rogmark C, Garellick G, Kärrholm J. Early mortality and morbidity after total hip arthroplasty in patients with femoral neck fracture. Acta Orthop 2016; 87(6): 560–6.
  • Hawker G A, Croxford R, Bierman A S, Harvey P J, Ravi B, Stanaitis I, Lipscombe L L. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLoS ONE 2014; 9(3): e91286.
  • Jacobsen S, Sonne-Holm S. Hip dysplasia: a significant risk factor for the development of hip osteoarthritis. A cross-sectional survey. Rheumatology (Oxford) 2005; 44(2): 211–18.
  • Johansson L A, Björkenstam C, Westerling R. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009; 62(11): 1202–9.
  • Lie S A, Engesaeter L B, Havelin L I, Gjessing H K, Vollset S E. Mortality after total hip replacement: 0–10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand 2000; 71(1): 19–27.
  • Ludvigsson J F, Andersson E, Ekbom A, Feychting M, Kim J-L, Reuterwall C, Heurgren M, Olausson P O. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11:450.
  • McNutt L-A, Wu C, Xue X, Hafner J P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003; 157(10): 940–3.
  • Perry D C, Metcalfe D, Costa M L, Van Staa T. A nationwide cohort study of slipped capital femoral epiphysis. Arch Dis Child 2017; 102(12): 1132.
  • Pun S. Hip dysplasia in the young adult caused by residual childhood and adolescent-onset dysplasia. Curr Rev Musculoskelet Med 2016; 9(4): 427–34.
  • Sjölander A, Greenland S. Ignoring the matching variables in cohort studies: when is it valid and why? Stat Med 2013; 32(27): 4696–708.
  • Söderman P. On the validity of the results from the Swedish National Total Hip Arthroplasty register. Acta Orthop Scand Suppl 2000; 71(296): 1–33.
  • Thillemann T M, Pedersen A B, Johnsen S P, Søballe K, Danish Hip Arthroplasty Registry. Implant survival after primary total hip arthroplasty due to childhood hip disorders: results from the Danish Hip Arthroplasty Registry. Acta Orthop 2008; 79(6): 769–76.
  • Traina F, De Fine M, Sudanese A, Calderoni P P, Tassinari E, Toni A. Long-term results of total hip replacement in patients with Legg–Calvé–Perthes disease. J Bone Joint Surg Am 2011; 93(7): e25.
  • Turkiewicz A, Kiadaliri A A, Englund M. Cause-specific mortality in osteoarthritis of peripheral joints. Osteoarthritis Cartilage 2019; 27(6): 848–54.
  • Ucpunar H, Camurcu I Y, Duman S, Ucpunar E, Sofu H, Bayhan A I. Obesity-related metabolic and endocrine disorders diagnosed during postoperative follow-up of slipped capital femoral epiphysis. Acta Orthop 2018; 89(3): 314–19.
  • Weiss R J, Kärrholm J, Rolfson O, Hailer N P. Increased early mortality and morbidity after total hip arthroplasty in patients with socioeconomic disadvantage: a report from the Swedish Hip Arthroplasty Register. Acta Orthop 2019; 90(3): 264–9.